SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

A once-weekly injection of Wegovy® has become available in Singapore, marking the latest step in managing obesity as a chronic disease. The product, from Novo Nordisk, is licensed for adults and those ...

Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and ...

JPMorgan said Eli Lilly is enrolling about 500,000 new obesity drug patients per month, and maintains more than 60% share in ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...